Literature DB >> 26396189

Sickle Cell Hemoglobin in the Ferryl State Promotes βCys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10).

Tigist Kassa1, Sirsendu Jana1, Michael Brad Strader1, Fantao Meng1, Yiping Jia1, Michael T Wilson2, Abdu I Alayash3.   

Abstract

Polymerization of intraerythrocytic deoxyhemoglobin S (HbS) is the primary molecular event that leads to hemolytic anemia in sickle cell disease (SCD). We reasoned that HbS may contribute to the complex pathophysiology of SCD in part due to its pseudoperoxidase activity. We compared oxidation reactions and the turnover of oxidation intermediates of purified human HbS and HbA. Hydrogen peroxide (H2O2) drives a catalytic cycle that includes the following three distinct steps: 1) initial oxidation of ferrous (oxy) to ferryl Hb; 2) autoreduction of the ferryl intermediate to ferric (metHb); and 3) reaction of metHb with an additional H2O2 molecule to regenerate the ferryl intermediate. Ferrous and ferric forms of both proteins underwent initial oxidation to the ferryl heme in the presence of H2O2 at equal rates. However, the rate of autoreduction of ferryl to the ferric form was slower in the HbS solutions. Using quantitative mass spectrometry and the spin trap, 5,5-dimethyl-1-pyrroline-N-oxide, we found more irreversibly oxidized βCys-93in HbS than in HbA. Incubation of the ferric or ferryl HbS with cultured lung epithelial cells (E10) induced a drop in mitochondrial oxygen consumption rate and impairment of cellular bioenergetics that was related to the redox state of the iron. Ferryl HbS induced a substantial drop in the mitochondrial transmembrane potential and increases in cytosolic heme oxygenase (HO-1) expression and mitochondrial colocalization in E10 cells. Thus, highly oxidizing ferryl Hb and heme, the product of oxidation, may be central to the evolution of vasculopathy in SCD and may suggest therapeutic modalities that interrupt heme-mediated inflammation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  bioenergetics; hemoglobin; mitochondria; oxidative stress; oxygen radicals

Mesh:

Substances:

Year:  2015        PMID: 26396189      PMCID: PMC4646035          DOI: 10.1074/jbc.M115.651257

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes.

Authors:  Marek Cyrklaff; Cecilia P Sanchez; Nicole Kilian; Cyrille Bisseye; Jacques Simpore; Friedrich Frischknecht; Michael Lanzer
Journal:  Science       Date:  2011-11-10       Impact factor: 47.728

Review 2.  Mitochondria: master regulators of danger signalling.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12       Impact factor: 94.444

Review 3.  Protein carbonylation, mitochondrial dysfunction, and insulin resistance.

Authors:  Brigitte I Frohnert; David A Bernlohr
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

4.  Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy.

Authors:  Ashlee N Higdon; Gloria A Benavides; Balu K Chacko; Xiaosen Ouyang; Michelle S Johnson; Aimee Landar; Jianhua Zhang; Victor M Darley-Usmar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

5.  Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine β145.

Authors:  Chris E Cooper; Dominik J Schaer; Paul W Buehler; Michael T Wilson; Brandon J Reeder; Gary Silkstone; Dimitri A Svistunenko; Leif Bulow; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2012-08-06       Impact factor: 8.401

6.  Isolated Hb Providence β82Asn and β82Asp fractions are more stable than native HbA(0) under oxidative stress conditions.

Authors:  Bindu Abraham; Wayne Hicks; Yiping Jia; Jin Hyen Baek; Jeffery L Miller; Abdu I Alayash
Journal:  Biochemistry       Date:  2011-10-21       Impact factor: 3.162

7.  Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.

Authors:  Alex George; Suvarnamala Pushkaran; Diamantis G Konstantinidis; Sebastian Koochaki; Punam Malik; Narla Mohandas; Yi Zheng; Clinton H Joiner; Theodosia A Kalfa
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

8.  Structure of fully liganded Hb ζ2β2s trapped in a tense conformation.

Authors:  Martin K Safo; Tzu-Ping Ko; Osheiza Abdulmalik; Zhenning He; Andrew H-J Wang; Eric R Schreiter; J Eric Russell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20

Review 9.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

10.  α-Hemoglobin stabilizing protein (AHSP) markedly decreases the redox potential and reactivity of α-subunits of human HbA with hydrogen peroxide.

Authors:  Todd L Mollan; Sambuddha Banerjee; Gang Wu; Claire J Parker Siburt; Ah-Lim Tsai; John S Olson; Mitchell J Weiss; Alvin L Crumbliss; Abdu I Alayash
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

View more
  30 in total

1.  Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.

Authors:  Tigist Kassa; M B Strader; Akito Nakagawa; Warren M Zapol; Abdu I Alayash
Journal:  Metallomics       Date:  2017-09-20       Impact factor: 4.526

2.  Determination of extinction coefficients of human hemoglobin in various redox states.

Authors:  Fantao Meng; Abdu I Alayash
Journal:  Anal Biochem       Date:  2017-01-06       Impact factor: 3.365

3.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

Review 4.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

5.  Melting of Hemoglobin in Native Solutions as measured by IMS-MS.

Authors:  Daniel W Woodall; Christopher J Brown; Shannon A Raab; Tarick J El-Baba; Arthur Laganowsky; David H Russell; David E Clemmer
Journal:  Anal Chem       Date:  2020-02-07       Impact factor: 6.986

Review 6.  Oxidative pathways in the sickle cell and beyond.

Authors:  Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2017-05-20       Impact factor: 3.039

Review 7.  Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.

Authors:  Michael Brad Strader; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2016-10-20       Impact factor: 8.401

8.  Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.

Authors:  Narendranath Reddy Chintagari; Sirsendu Jana; Abdu I Alayash
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 9.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

Review 10.  βCysteine 93 in human hemoglobin: a gateway to oxidative stability in health and disease.

Authors:  Abdu I Alayash
Journal:  Lab Invest       Date:  2020-09-26       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.